Edwards Lifesciences Corp (EW) Financials

$85.31

$0.94 (1.11%)

As on 14-Sep-2026 12:43EDT

Market cap

$48,631 Mln

Revenue (TTM)

$6,512 Mln

P/E Ratio

50.2

P/B Ratio

4.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	6,512.30	6,067.60	5,439.50	6,004.80	5,382.40	5,232.50
Cost of Revenue	1,435.70	1,326.90	1,117.50	1,379.80	1,167.20	1,225.90
Gross Profit	5,078.30	4,740.70	4,322.00	4,625.00	4,215.20	4,006.60
Operating Expenses	3,248.70	3,104.50	2,943.30	2,896.40	2,512.80	2,396.20
Operating Profit (EBIT)	1,829.60	1,636.20	1,378.70	1,534.10	1,702.40	1,610.40
Other Income	--	--	--	--	38.10	30.10
Profit before Tax	1,417.60	1,272.90	1,548.10	1,598.10	1,767.40	1,702.00
Provision for Tax	439.00	216.90	152.10	198.70	245.50	198.90
Profit after Tax (Net Income)	1,004.90	1,073.50	4,174.60	1,402.40	1,521.90	1,503.10
Minority Interest	1.30	4.10	4.90	3.00	--	--
Consolidated Profit	382.30	1,073.50	4,174.60	1,402.40	1,521.90	1,503.10

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	10,618.00	10,337.60	9,998.40	6,650.00	5,806.70	5,835.90
Minority Interest	1.30	--	--	--	--	--
Non-Current Liabilities	1,634.30	1,545.90	1,487.20	1,448.40	1,463.40	1,634.40
Current Liabilities	1,507.90	1,813.70	1,505.20	1,195.40	1,022.40	1,032.30
Total Liabilities	15,375.00	13,697.20	13,055.30	9,363.20	8,292.50	8,502.60

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	7,048.20	6,958.30	6,769.90	5,327.50	5,196.70	5,321.90
Current Assets	6,818.90	6,738.90	6,285.40	4,035.70	3,095.80	3,180.70
Total Assets	15,375.00	13,697.20	13,055.30	9,363.20	8,292.50	8,502.60
Total Debt*	704.40	705.40	700.00	685.10	691.30	690.30
Net Current Assets	5,311.00	4,925.20	4,780.20	2,840.30	2,073.40	2,148.40

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	1,595.20	542.30	895.80	1,218.20	1,732.10
Cash Flow from Investing Activities	--	-712.90	2,312.90	173.80	252.30	-1,722.50
Cash from Financing Activities	--	-956.80	-983.00	-711.00	-1,584.50	-356.30
Net Cash Inflow / Outflow	--	--	--	--	-114.00	-346.70

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	1.73	1.85	7.07	2.31	2.47	2.38
Cash EPS ($)	1.68	2.11	7.33	2.55	2.70	2.59
Adjusted Book Value ($)	18.42	17.77	16.93	10.96	9.42	9.23
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	2.74	0.92	1.48	1.98	2.74
Free Cash Flow per Share ($)	--	2.29	0.49	1.04	1.55	2.22

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	9.88	46.30	20.28	23.37	25.49
ROE (%)	9.60	10.56	50.15	22.52	26.14	28.88
ROA (%)	6.64	8.03	37.24	15.89	18.12	19.10
EBIT Margin (%)	13.79	20.98	28.82	25.55	33.32	33.00
Net Margin (%)	15.43	17.69	76.75	23.35	28.08	28.56
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	14.55	0.12	-0.09	0.12	0.03	0.19
EBIT Growth (%)	-44.97	-18.81	2.20	-14.47	3.87	83.92
Net Profit Growth (%)	-75.74	-74.28	197.68	-7.85	1.25	82.55
EPS Growth (%)	-75.16	-0.74	2.06	-0.06	0.04	0.83
Book Value Growth (%)	2.48	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	50.22	46.20	10.47	33.00	30.21	54.47
Price / Book Value	4.71	4.80	4.37	6.96	7.92	14.03
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	22.78	32.23	23.47	29.55	23.18	42.91
Close Price ($)	90.46	85.25	74.03	76.25	74.61	129.55
High Price ($)	92.88	87.89	96.12	94.87	131.10	131.73
Low Price ($)	72.30	65.94	58.93	60.57	67.13	78.44
Market Cap ($ Cr)	48,630.87	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.06	0.07	0.07	0.10	0.12	0.12
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	0.00
Current Ratio	4.52	3.72	4.18	3.38	3.03	3.08
Quick Ratio	3.77	3.09	3.45	2.62	2.17	2.38
Interest Coverage	--	62.40	79.19	87.16	68.46	69.63

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	14.68	15.03	13.37	13.79	12.99	12.71
Asset Turnover	0.43	0.45	0.49	0.68	0.64	0.66
Receivable days	--	49.35	52.22	46.45	46.28	44.25
Inventory Days	--	304.57	325.24	235.46	250.69	227.78
Payable days	--	58.48	62.75	51.42	63.59	59.74
Cash Conversion Cycle	--	295.43	314.71	230.49	233.38	212.29

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.